Characteristics of patients with EGPA and control subjects.

Values are given as number (percentage), mean ± SD or median (lower-upper quartile).Abbreviations: EGPA, eosinophilic granulomatosis with polyangiitis; ECP, eosinophil cationic protein; sCD40L, soluble CD40 ligand; CRP, C-reactive protein; t-PA, tissue plasminogen activator; PAI-1, plasminogen activator inhibitor-1; TAFI, thrombin activatable fibrinolysis inhibitor.Characteristics of patients with EGPA and control subjects.数据以数值（百分比）、均值±标准差（standard deviation, SD）或中位数（下四分位数-上四分位数）形式给出。缩写说明：EGPA为嗜酸性肉芽肿性多血管炎（eosinophilic granulomatosis with polyangiitis）；ECP为嗜酸性粒细胞阳离子蛋白（eosinophil cationic protein）；sCD40L为可溶性CD40配体（soluble CD40 ligand）；CRP为C反应蛋白（C-reactive protein）；t-PA为组织型纤溶酶原激活物（tissue plasminogen activator）；PAI-1为纤溶酶原激活物抑制剂-1（plasminogen activator inhibitor-1）；TAFI为凝血酶激活纤溶抑制物（thrombin activatable fibrinolysis inhibitor）。嗜酸性肉芽肿性多血管炎患者与对照受试者的临床特征。